Browse Categories

Publications by authors named "Thomas F Kaye"

  • Page 1 of 1
CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma.
Clinton W Ali Thomas F Kaye Douglas J A Adamson Iain S Tait Francesco M Polignano

J Gastrointest Cancer

February 2009

Background: The CA 19-9 tumour marker is increasingly used to monitor response to therapy in patients with pancreatic adenocarcinoma. Serum CA 19-9 levels have also been shown to correlate with survival. However, their role in cholangiocarcinoma is less clear.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Thomas F Kaye"

  • - Thomas F Kaye's research primarily focuses on the role of the CA 19-9 tumor marker in assessing treatment responses and survival outcomes in patients with advanced pancreatic adenocarcinoma and cholangiocarcinoma.
  • - His 2009 study highlights that while CA 19-9 levels are correlated with survival in pancreatic adenocarcinoma, its significance in cholangiocarcinoma remains uncertain.
  • - Kaye's work contributes to a better understanding of biomarker usage in clinical settings, aiming to enhance patient management strategies for these challenging cancer types.

Privacy Policy Site Map

© LitMetric 2025. All rights reserved.